Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Inside information: Orion upgrades full-year outlook for 2024 and provides preliminary information on financial performance for 2024 ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION15...
Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2025 Annual General Meeting ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED...
79,345 Orion Corporation A shares converted into B shares ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE13 JANUARY 2025 at 9.50 EET...
Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide ORION CORPORATION INVESTOR NEWS 7 JANUARY 2025 at 9:00 EET Orion’s collaboration...
Orion and Marinus terminate agreement for ganaxolone in Europe ORION CORPORATION PRESS RELEASE 30 DECEMBER 2024 at 14.00 EET Orion and Marinus terminate agreement for ganaxolone in...
CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES...
Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS19...
Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics ORION CORPORATION PRESS RELEASE 18 DECEMBER 2024 at 17.00...
Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES...
142,701 Orion Corporation A shares converted into B shares ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE27 NOVEMBER 2024 at 9.00 EET...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
